Cargando…

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML

Detalles Bibliográficos
Autores principales: Tettero, Jesse M., Buisman, Yara, Ngai, Lok Lam, Bachas, Costa, Gjertsen, Bjorn T., Kelder, Angèle, van de Loosdrecht, Arjan A., Manz, Markus G., Pabst, Thomas, Scholten, Willemijn, Ossenkoppele, Gert J., Cloos, Jacqueline, de Leeuw, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664848/
https://www.ncbi.nlm.nih.gov/pubmed/38026789
http://dx.doi.org/10.1097/HS9.0000000000000981
_version_ 1785148799910412288
author Tettero, Jesse M.
Buisman, Yara
Ngai, Lok Lam
Bachas, Costa
Gjertsen, Bjorn T.
Kelder, Angèle
van de Loosdrecht, Arjan A.
Manz, Markus G.
Pabst, Thomas
Scholten, Willemijn
Ossenkoppele, Gert J.
Cloos, Jacqueline
de Leeuw, David C.
author_facet Tettero, Jesse M.
Buisman, Yara
Ngai, Lok Lam
Bachas, Costa
Gjertsen, Bjorn T.
Kelder, Angèle
van de Loosdrecht, Arjan A.
Manz, Markus G.
Pabst, Thomas
Scholten, Willemijn
Ossenkoppele, Gert J.
Cloos, Jacqueline
de Leeuw, David C.
author_sort Tettero, Jesse M.
collection PubMed
description
format Online
Article
Text
id pubmed-10664848
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106648482023-11-21 Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML Tettero, Jesse M. Buisman, Yara Ngai, Lok Lam Bachas, Costa Gjertsen, Bjorn T. Kelder, Angèle van de Loosdrecht, Arjan A. Manz, Markus G. Pabst, Thomas Scholten, Willemijn Ossenkoppele, Gert J. Cloos, Jacqueline de Leeuw, David C. Hemasphere Letter Lippincott Williams & Wilkins 2023-11-21 /pmc/articles/PMC10664848/ /pubmed/38026789 http://dx.doi.org/10.1097/HS9.0000000000000981 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Letter
Tettero, Jesse M.
Buisman, Yara
Ngai, Lok Lam
Bachas, Costa
Gjertsen, Bjorn T.
Kelder, Angèle
van de Loosdrecht, Arjan A.
Manz, Markus G.
Pabst, Thomas
Scholten, Willemijn
Ossenkoppele, Gert J.
Cloos, Jacqueline
de Leeuw, David C.
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
title Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
title_full Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
title_fullStr Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
title_full_unstemmed Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
title_short Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
title_sort prognostic significance of measurable residual disease detection by flow cytometry in autologous stem cell apheresis products in aml
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664848/
https://www.ncbi.nlm.nih.gov/pubmed/38026789
http://dx.doi.org/10.1097/HS9.0000000000000981
work_keys_str_mv AT tetterojessem prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT buismanyara prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT ngailoklam prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT bachascosta prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT gjertsenbjornt prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT kelderangele prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT vandeloosdrechtarjana prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT manzmarkusg prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT pabstthomas prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT scholtenwillemijn prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT ossenkoppelegertj prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT cloosjacqueline prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml
AT deleeuwdavidc prognosticsignificanceofmeasurableresidualdiseasedetectionbyflowcytometryinautologousstemcellapheresisproductsinaml